KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $131,257 | +496.6% | 38,605 | +681.3% | 0.00% | – |
| Q2 2022 | $22,000 | -95.6% | 4,941 | -80.9% | 0.00% | -100.0% |
| Q1 2020 | $496,000 | -96.8% | 25,818 | -96.8% | 0.00% | -97.1% |
| Q4 2019 | $15,667,000 | +2822.9% | 817,261 | +790.4% | 0.04% | +3400.0% |
| Q1 2019 | $536,000 | -80.5% | 91,782 | -68.7% | 0.00% | -85.7% |
| Q4 2018 | $2,749,000 | -45.4% | 293,399 | -0.8% | 0.01% | -41.7% |
| Q3 2018 | $5,038,000 | +11895.2% | 295,854 | +11995.4% | 0.01% | – |
| Q2 2018 | $42,000 | +1300.0% | 2,446 | +1037.7% | 0.00% | – |
| Q1 2018 | $3,000 | – | 215 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |